Clozapine, sold under the brand name Clozaril among others, is a psychiatric medication and was the first atypical antipsychotic to be discovered. It is used primarily to treat people with schizophrenia and schizoaffective disorder who have had an inadequate response to two other antipsychotics, or who have been unable to tolerate other drugs due to extrapyramidal side effects. In the US, clozapine is also approved for use in people with recurrent suicidal behavior in people with schizophrenia or schizoaffective disorder. It is also used for the treatment of psychosis in Parkinson's disease.
Clozapina molecular structure diagram from the DrugsPRO substance library.
Also known as: Clozapine hydrochloride
Classification
Chemical: Medicine
Psychoactive: Depressant
Tag: Antipsychotic
Tag: Atypical antipsychotic
Tag: Pharmaceutical
Effects
Sedation
Motor Impairment
Dry Mouth
Fatigue
Akathisia Like Movement
Itchiness
Reduced Anxiety
Anxiety Suppression
Dizziness
Motor Control Loss
Drowsiness
Euphoria
Dulled Perception
Open Eye Visuals
Cognitive Dysphoria
Dehydration
Appetite Change
Entity Imagery
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Clozapine - Guida alle sostanze DrugsPRO
Clozapine: Clozapine, sold under the brand name Clozaril among others, is a psychiatric medication and was the first atypical antipsychotic to be discovered. It is used primarily to treat people with schizophrenia and schizoaffective disorder who have had an inadequate response to two other antipsyc